18.11.2014 Views

09/2009 - Državni zavod za intelektualno vlasništvo

09/2009 - Državni zavod za intelektualno vlasništvo

09/2009 - Državni zavod za intelektualno vlasništvo

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

HR - Patenti - Hrvatski glasnik <strong>intelektualno</strong>g vlasništva 16, 20<strong>09</strong>, 9, 3373 – 3601 3517<br />

MKP Broj objave europske Naziv izuma<br />

prijave patenta<br />

(51) (97) (54)<br />

A61P 31/04 (2006.01) EP 2<strong>09</strong>9759 * ANTIBACTERIAL QUINOLINE DERIVATIVES<br />

A61P 31/04 (2006.01) EP 2<strong>09</strong>9761 * ANTIBACTERIAL QUINOLINE DERIVATIVES<br />

A61P 31/04 (2006.01) EP 2<strong>09</strong>9762 * ANTIBACTERIAL QUINOLINE DERIVATIVES<br />

A61P 31/06 (2006.01) EP 2086940 * FUMARATE SALT OF (ALPHA S, BETA R)-6-BROMO-ALPHA-[2-(DIMETHYLAMINO)ETHYL]-<br />

2-METHOXY-ALPHA-1-NAPHTHALENYL-BETA-PHENYL-3-QUINOLINEETHANOL<br />

A61P 31/06 (2006.01) EP 2086941 * ANTIBACTERIAL QUINOLINE DERIVATIVES<br />

A61P 31/12 (2006.01) EP 2086980 * MACROCYCLIC PEPTIDES AS HEPATITIS C VIRUS INHIBITORS<br />

A61P 31/12 (2006.01) EP 2089020 * MACROCYCLIC PEPTIDES AS HEPATITIS C VIRUS INHIBITORS<br />

A61P 31/12 (2006.01) EP 2<strong>09</strong>1946 * PIPERIDINE DERIVATIVE USED FOR TREATING CHEMOKINE RECEPTOR 5 MEDIATED<br />

DISEASES<br />

A61P 31/12 (2006.01) EP 2<strong>09</strong>9778 * AMIDO ANTI-VIRAL COMPOUNDS<br />

A61P 31/14 (2006.01) EP 2086963 * HEPATITIS C VIRUS INHIBITORS<br />

A61P 31/14 (2006.01) EP 2086994 * INHIBITORS OF HEPATITIS C VIRUS<br />

A61P 31/14 (2006.01) EP 2<strong>09</strong>7084 * CARBOXAMIDE 4-[(4-PYRIDYL)AMINO] PYRIMIDINES FOR THE TREATMENT OF<br />

HEPATITIS C<br />

A61P 31/14 (2006.01) EP 2<strong>09</strong>7402 * MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS<br />

A61P 31/14 (2006.01) EP 2<strong>09</strong>9778 * AMIDO ANTI-VIRAL COMPOUNDS<br />

A61P 31/16 (2006.01) EP 2086582 * VACCINE COMPRISING AN OIL IN WATER EMULSION ADJUVANT<br />

A61P 33/00 (2006.01) EP 2<strong>09</strong>74<strong>09</strong> * 2-SUBSTITUTED-6-HETEROCYCLIC PYRIMIDONE DERIVATIVES AS TAU PROTEIN<br />

KINASE 1 INHBITORS<br />

A61P 35/00 (2006.01) EP 1935415 Treatment of androgen-deprivation induced osteoporosis<br />

A61P 35/00 (2006.01) EP 2020410 Pyrido[2,3d]pyrimidine derivatives, process for their preparation and their therapeutical use<br />

A61P 35/00 (2006.01) EP 2086644 * COMBINATION OF AN INHIBITOR OF DNA POLYMERASE-ALPHA AND AN INHIBITOR OF A<br />

CHECKPOINT KINASE FOR PROLIFERATIVE DISORDERS<br />

A61P 35/00 (2006.01) EP 2086933 * NOVEL INDOLE DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND<br />

PHARMACEUTICAL COMPOSITIONS CONTAINING THEM<br />

A61P 35/00 (2006.01) EP 2086979 * IMIDAZOÝ1,2-B¨PYRIDAZINE AND PYRAZOLOÝ1,5-A¨PYRIMIDINE DERIVATIVES AND<br />

THEIR USE AS PROTEIN KINASE INHIBITORS<br />

A61P 35/00 (2006.01) EP 2086981 * COMPOUNDS FOR INHIBITING MITOTIC PROGRESSION<br />

A61P 35/00 (2006.01) EP 2087103 * CANCEROUS DISEASE MODIFYING ANTIBODIES<br />

A61P 35/00 (2006.01) EP 2087112 * TARGETING OF ALPHA-1 OR ALPHA-3 SUBUNIT OF NA+, K+-ATPASE IN THE<br />

TREATMENT OF PROLIFERATIVE DISEASES<br />

A61P 35/00 (2006.01) EP 2089024 * COMBINATION OF IAP INHIBITORS AND FLT3 INHIBITORS<br />

A61P 35/00 (2006.01) EP 2089042 * METHODS FOR IMPROVED ENGRAFTMENT FOLLOWING STEM CELL<br />

TRANSPLANTATION<br />

A61P 35/00 (2006.01) EP 2089364 * PYRIDINONE COMPOUNDS<br />

A61P 35/00 (2006.01) EP 2089395 * NEW ISOCARBOSTYRIL ALKALOID DERIVATIVES HAVING ANTI-PROLIFERATIVE AND<br />

ANTI-MIGRATORY ACTIVITIES<br />

A61P 35/00 (2006.01) EP 2089514 * CANCEROUS DISEASE MODIFYING ANTIBODIES<br />

A61P 35/00 (2006.01) EP 2<strong>09</strong>1919 * DERIVATIVES OF 18-AMINO SUBSTITUTED ANALOGS OF THE GELDAMYCIN<br />

HYDROQUINON WITH CYTOTOXIC ACTIVITY FOR THE TREATMENT OF CANCER<br />

A61P 35/00 (2006.01) EP 2<strong>09</strong>1920 * SUBSTITUTED PYRAZOLES, COMPOSITIONS CONTAINING THESE, METHOD OF<br />

PRODUCTION AND USE<br />

A61P 35/00 (2006.01) EP 2<strong>09</strong>1926 * SUBSTITUTED PYRAZOLE AND TRIAZOLE COMPOUNDS AS KSP INHIBITORS<br />

A61P 35/00 (2006.01) EP 2<strong>09</strong>1941 * MAPK/ERK KINASE INHIBITORS<br />

A61P 35/00 (2006.01) EP 2<strong>09</strong>2058 * CANCEROUS DISEASE MODIFYING ANTIBODIES<br />

A61P 35/00 (2006.01) EP 2<strong>09</strong>3228 * PYRROLINE-2-ONE DERIVATIVES AGAINST CELL RELEASING TUMOR NECROSIS<br />

FACTOR, PREPARATION METHODS AND USES THEREOF<br />

A61P 35/00 (2006.01) EP 2<strong>09</strong>4673 * COMPOUNDS AND METHODS FOR INHIBITING THE INTERACTION OF BCL PROTEINS<br />

WITH BINDING PARTNERS<br />

A61P 35/00 (2006.01) EP 2<strong>09</strong>4699 * PHARMACEUTICAL COMPOSITIONS, AND USE THEREOF AS PROTEIN KINASE<br />

INHIBITORS, IN PARTICULAR CDC7<br />

NEW IMIDAZOLONE DERIVATIVES, PREPARATION THEREOF AS DRUGS,<br />

A61P 35/00 (2006.01) EP 2<strong>09</strong>4700 * SALTS AND CRYSTALL FORMS OF 2-METHYL-2-[4-(3-METHYL-2-OXO-8-QUINOLIN-3-YL-<br />

2,3-DIHYDRO-IMIDAZO[4,5-C]QUINOLIN-1-YL)-PHENYL]-PROPIONITRILE<br />

A61P 35/00 (2006.01) EP 2<strong>09</strong>4701 * COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR<br />

A61P 35/00 (2006.01) EP 2<strong>09</strong>4707 * HETEROBICYCLIC MATRIX METALLOPROTEASE INHIBITORS<br />

A61P 35/00 (2006.01) EP 2<strong>09</strong>4713 * EPOTHILONE ANALOGUES MODIFIED AT POSITIONS C12-C13 AS ANTICANCER DRUGS<br />

A61P 35/00 (2006.01) EP 2<strong>09</strong>6122 * ANTI-HUMAN DLK-1 ANTIBODY SHOWING ANTI-TUMOR ACTIVITY IN VIVO<br />

A61P 35/00 (2006.01) EP 2<strong>09</strong>6167 * APTAMER AGAINST MIDKINE AND USE THEREOF<br />

A61P 35/00 (2006.01) EP 2<strong>09</strong>7386 * SUBSTITUTED DIHYDROIMIDAZOLES AND THEIR USE IN THE TREATMENT OF TUMORS<br />

A61P 35/00 (2006.01) EP 2<strong>09</strong>74<strong>09</strong> * 2-SUBSTITUTED-6-HETEROCYCLIC PYRIMIDONE DERIVATIVES AS TAU PROTEIN<br />

KINASE 1 INHBITORS<br />

A61P 35/00 (2006.01) EP 2<strong>09</strong>7414 * PYRROLO [2, 3-B]PYRIDINE DERIVATIVES AS KINASE MODULATORS<br />

A61P 35/00 (2006.01) EP 2<strong>09</strong>8595 * HLA-A*1101-RESTRICTED WT1 PEPTIDE AND PHARMACEUTICAL COMPOSITION<br />

COMPRISING THE SAME<br />

A61P 35/00 (2006.01) EP 2<strong>09</strong>9796 * AZA-INDOLYL COMPOUNDS AND METHODS OF USE<br />

ISSN 1331-2030

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!